ICD-10-CM Billable Code

G31.85

Corticobasal degeneration

Clinical Classification Guidelines

Medical Intelligence & Overview

Corticobasal degeneration (CBD) is a rare neurological disorder that primarily affects movement, speech, and other functions controlled by the brain. It is classified under ICD-10 code G31.85. CBD is one of the atypical parkinsonian syndromes, characterized by a progressive decline in brain function due to abnormal protein deposits in specific brain regions. As a progressive disorder, CBD can significantly impact daily life and functional abilities over time.

Causes & Symptoms

Clinical Causes: T h e e x a c t c a u s e o f c o r t i c o b a s a l d e g e n e r a t i o n r e m a i n s u n k n o w n . H o w e v e r , i t i s b e l i e v e d t o i n v o l v e a b n o r m a l a c c u m u l a t i o n o f a p r o t e i n c a l l e d t a u w i t h i n b r a i n c e l l s , l e a d i n g t o t h e i r d e g e n e r a t i o n . T h e s e t a u d e p o s i t s i n t e r f e r e w i t h n o r m a l c e l l f u n c t i o n a n d c o m m u n i c a t i o n , p a r t i c u l a r l y i n a r e a s r e s p o n s i b l e f o r m o v e m e n t a n d c o g n i t i o n . G e n e t i c f a c t o r s m a y p l a y a r o l e i n s o m e c a s e s , b u t m o s t c a s e s o c c u r s p o r a d i c a l l y w i t h o u t a c l e a r i n h e r i t e d p a t t e r n .

Key Symptoms: Impaired movement, such as stiffness, rigidity, and awkward gait Limb apraxia, making it difficult to perform purposeful movements Asymmetry in motor symptoms, often affecting one side of the body more than the other Dystonia, characterized by abnormal postures or twisting movements Bradykinesia, or slowed movement Difficulty with speech and swallowing Cognitive impairments, including problems with judgment, attention, and language Myoclonus or involuntary jerky movements Sensory deficits, such as decreased sensation or numbness Eye movement abnormalities, including problems with gaze and eyelid movements Behavioral changes, which may include apathy or mood alterations

Diagnostic & Treatment

Diagnosis Path: Comprehensive neurological examination Magnetic resonance imaging (MRI) to identify brain atrophy, especially in the parietal and frontal lobes Positron emission tomography (PET) scans that can show reduced metabolic activity in affected brain regions Blood tests to exclude other causes of similar symptoms Possible genetic testing if familial forms are suspected

Treatment Protocols: Medications such as levodopa or dopamine agonists to address motor symptoms, although responses can vary Physical therapy aimed at maintaining mobility and preventing contractures Speech therapy to support communication and swallowing difficulties Occupational therapy to assist with daily activities and adapt the environment Supportive interventions including assistive devices and adaptive techniques Addressing behavioral and cognitive symptoms through counseling or medications if appropriate

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is G31.85 a billable ICD-10 code?
Yes, G31.85 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report G31.85?
Clinical documentation must specify the nature of Corticobasal degeneration and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Clinical Meta Tags

corticobasal degeneration